On 21 October 2025, TATA Health International Holdings Limited (Incorporated in the Cayman Islands with limited liability; stock code: 1255) provided an update on its board of directors. The Board comprises one executive director, two non-executive directors, and four independent non-executive directors. The executive director is Mr. Zhang Ming Qi. The non-executive directors are Mr. Chu Chun Ho, Dominic and Mr. Chen Qi. The independent non-executive directors are Ms. Huang Lin, Mr. Li Liang, Mr. Du Jianfeng, and Mr. Tan Kaiguo.

In conjunction with the announcement, the Audit Committee is chaired by Mr. Tan Kaiguo, with Mr. Li Liang and Mr. Du Jianfeng as committee members. The Remuneration Committee is chaired by Ms. Huang Lin, with Mr. Li Liang and Mr. Du Jianfeng. The Nomination Committee is also chaired by Ms. Huang Lin, joined by Mr. Li Liang and Mr. Du Jianfeng.